Immunocore Holdings plc - American Depositary Shares — キャッシュフロー (NASDAQ:IMCR)

Financials

営業活動によるキャッシュフロー ———2.94 M26.06 M-10.71 M -10.71 M 投資活動によるキャッシュフロー ———-5.42 M-355.13 M-16.34 M -16.34 M 財務活動によるキャッシュフロー ———34.35 M343.88 M12.37 M 12.37 M フリーキャッシュフロー ———-2.48 M20.89 M-15.05 M -15.05 M

Immunocore Holdings plc - American Depositary Shares

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

IMCR

Financials

Immunocore Holdings plc - American Depositary Shares

ニュース

Ideaya Biosciences Surges On Promising Results For Hard-To-Treat Melanoma

Jefferies、収益懸念でImmunocore株の格付けを引き下げ

Jefferies downgrades Immunocore stock rating on revenue concerns

Immunocore、Leerinkカンファレンスで戦略的成長とイノベーションを発表

Immunocore at Leerink Conference: Strategic Growth and Innovation

Immunocore Holdings plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IMCR) 2026-02-25

Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript

【決算速報】イミューノコアホールディングス、売上高は予想を下回り、利益は予想を下回る結果に

Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates

JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up

Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y